Drug Profile
Anthrax vaccine (Trithrax) - Buckler Diodefense
Alternative Names: Anthrax vaccine (Trithrax) - Virionyx/Zeptometrix; TrithraxLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Buckler Biodefence Corp
- Developer Buckler Biodefense
- Class Anthrax vaccines
- Mechanism of Action Anthrax toxin inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anthrax
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Anthrax in New Zealand
- 04 Nov 2017 No recent reports of development identified for preclinical development in Anthrax in USA
- 11 Jul 2007 This vaccine programme is still in active development